{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:36:00Z","timestamp":1787236560893,"version":"build-2736575974"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Randomized controlled trials (RCTs) are the cornerstone of evidence-based medicine, yet their distribution across clinical disciplines is far from uniform. Nephrology and kidney failure are a striking example of fields where the number, quality, and applicability of trials remain suboptimal, despite the high disease burden and cost of care. The dearth of high-quality trials persists due to numerous systemic and practical barriers, including the unwillingness of patients and clinicians to participate, ethical constraints, logistical complexity, and financial limitations. These barriers are compounded by the typical exclusion of vulnerable populations (frail individuals) from trials, thereby limiting generalizability. In this narrative review, we examine why RCTs remain scarce in these specific fields and propose innovative methodological solutions to address this persistent gap. We discuss target trial emulation using real-world data as a powerful approach to approximate RCT-level causal inference, with particular reference to trials in hemodialysis. We further explore the emerging field of digital twins, ie AI-powered, data-driven simulations of individual patients, and their use in conducting fully virtual randomized trials. Through these examples, we outline a potential path towards a more inclusive, efficient, and timely evidence-generation framework for disciplines historically underserved by traditional trial infrastructure.<\/jats:p>","DOI":"10.1093\/joneph\/aajag032","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:41:43Z","timestamp":1770122503000},"page":"663-673","source":"Crossref","is-referenced-by-count":0,"title":["From challenge to innovation: a narrative review on innovation in nephrology and hemodialysis randomized trials"],"prefix":"10.1093","volume":"39","author":[{"given":"Vasileios C","family":"Pezoulas","sequence":"first","affiliation":[{"name":"Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina , Ioannina GR45110 ,","place":["Greece"]},{"name":"Biomedical Research Institute\u2014FORTH , Ioannina GR45110 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tachos","sequence":"additional","affiliation":[{"name":"Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina , Ioannina GR45110 ,","place":["Greece"]},{"name":"Biomedical Research Institute\u2014FORTH , Ioannina GR45110 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios I","family":"Fotiadis","sequence":"additional","affiliation":[{"name":"Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina , Ioannina GR45110 ,","place":["Greece"]},{"name":"Biomedical Research Institute\u2014FORTH , Ioannina GR45110 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology (CNR-IFC) , Reggio Calabria ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1996","authenticated-orcid":false,"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[{"name":"Renal Research Institute , New York, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krister","family":"Cromm","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin ,","place":["Germany"]},{"name":"Fresenius Medical Care Deutschland GmbH, Global Medical Office , Bad Homburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni F M","family":"Strippoli","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, The University of Sydney , Sydney, NSW ,","place":["Australia"]},{"name":"Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro , Bari ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"2026082009363719100_aajag032-B1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.ASN.0000100125.21491.46","article-title":"The number, quality, and coverage of randomized controlled trials in nephrology","volume":"15","author":"Strippoli","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2026082009363719100_aajag032-B2","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"2026082009363719100_aajag032-B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40620-024-02158-5","article-title":"Clinical trial emulation in nephrology","volume":"38","author":"Zoccali","year":"2025","journal-title":"J Nephrol"},{"key":"2026082009363719100_aajag032-B4","article-title":"Digital twinning: clinical trials powered by AI","volume":"22","author":"Klabunde","year":"2024","journal-title":"Sanofi Magazine"},{"key":"2026082009363719100_aajag032-B5","doi-asserted-by":"publisher","author":"Camps","DOI":"10.48550\/arXiv.2401.10029"},{"key":"2026082009363719100_aajag032-B6","doi-asserted-by":"publisher","author":"Camps","DOI":"10.48550\/arXiv.2306.13740"},{"key":"2026082009363719100_aajag032-B7","doi-asserted-by":"publisher","author":"Walsh","DOI":"10.48550\/arXiv.2002.02779"},{"key":"2026082009363719100_aajag032-B8","first-page":"S25","article-title":"Innovations needed in nephrology: too few and too small randomized trials hamper evidence-based practice","volume":"98","author":"Friedewald","year":"2020","journal-title":"Kidney Int"},{"key":"2026082009363719100_aajag032-B9","first-page":"287","article-title":"Epidemiology of hemodialysis outcomes: disparities in practice patterns and outcome heterogeneity","volume":"18","author":"Culleton","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"2026082009363719100_aajag032-B10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ki.2015.53","article-title":"Clinical outcomes of hemodialysis patients in longitudinal cohort studies","volume":"88","author":"Dialysis Outcomes and Practice Patterns Study (DOPPS) Investigators","year":"2015","journal-title":"Kidney Int"},{"key":"2026082009363719100_aajag032-B11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.kint.2020.03.046","article-title":"Global disparities in dialysis modalities: underutilization of home dialysis despite potential benefits","volume":"98","author":"Walker","year":"2020","journal-title":"Kidney Int"},{"key":"2026082009363719100_aajag032-B12","doi-asserted-by":"publisher","first-page":"e002146","DOI":"10.1136\/bmjopen-2012-002146","article-title":"Clinician beliefs and attitudes about home haemodialysis: a multinational interview study","volume":"2","author":"Tong","year":"2012","journal-title":"BMJ Open"},{"key":"2026082009363719100_aajag032-B13","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jama.298.11.joc601","article-title":"Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life","volume":"298","author":"Culleton","year":"2007","journal-title":"JAMA"},{"key":"2026082009363719100_aajag032-B14","doi-asserted-by":"publisher","first-page":"e0309773","DOI":"10.1371\/journal.pone.0309773","article-title":"Frequent hemodialysis versus standard hemodialysis for people with kidney failure: systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Natale","year":"2024","journal-title":"PLoS One"},{"key":"2026082009363719100_aajag032-B15","first-page":"S51","article-title":"Home dialysis: conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) controversies conference","volume":"104","author":"Perl","year":"2023","journal-title":"Kidney Int"},{"key":"2026082009363719100_aajag032-B16","first-page":"1103","article-title":"Intensive hemodialysis and mortality risk in Australian and New Zealand populations","volume":"90","author":"Marshall","year":"2016","journal-title":"Kidney Int"},{"key":"2026082009363719100_aajag032-B17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/BF02982619","article-title":"The under-representation of older people in clinical trials: barriers and potential solutions","volume":"12","author":"Habicht","year":"2008","journal-title":"J Nutr Health Aging"},{"key":"2026082009363719100_aajag032-B18","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.1111\/j.1532-5415.2010.02865.x","article-title":"Disparate inclusion of older adults in clinical trials","volume":"58","author":"Herrera","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"2026082009363719100_aajag032-B19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s11606-010-1655-z","article-title":"Inclusion and analysis of older adults in randomized controlled trials","volume":"26","author":"Zulman","year":"2011","journal-title":"J Gen Intern Med"},{"key":"2026082009363719100_aajag032-B20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bcp.15476","article-title":"Frailty in clinical drug trials: frailty assessments, representation, and outcomes","volume":"90","author":"Nguyen","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"2026082009363719100_aajag032-B21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40266-021-00914-6","article-title":"Clinical trials in older people: what we know, what we need to know","volume":"39","author":"Pitk\u00e4l\u00e4","year":"2022","journal-title":"Drugs Aging"},{"key":"2026082009363719100_aajag032-B22","doi-asserted-by":"publisher","author":"Wang","DOI":"10.48550\/arXiv.2402.07236"},{"key":"2026082009363719100_aajag032-B23","doi-asserted-by":"publisher","author":"Degtiar","DOI":"10.48550\/arXiv.2102.11904"},{"key":"2026082009363719100_aajag032-B24","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.289.10.1278","article-title":"Central challenges facing the national clinical research enterprise","volume":"289","author":"Sung","year":"2003","journal-title":"JAMA"},{"key":"2026082009363719100_aajag032-B25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1046\/j.1523-1755.2001.059002777.x","article-title":"Daily hemodialysis: rationale, benefits, and potential risks","volume":"59","author":"Rocco","year":"2001","journal-title":"Kidney Int"},{"key":"2026082009363719100_aajag032-B26","doi-asserted-by":"publisher","first-page":"e002148","DOI":"10.1136\/bmjopen-2012-002148","article-title":"The beliefs and expectations of patients and caregivers about home haemodialysis: an interview study","volume":"3","author":"Tong","year":"2013","journal-title":"BMJ Open"},{"key":"2026082009363719100_aajag032-B27","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.kint.2023.07.012","article-title":"Is hemodiafiltration superior to hemodialysis in patients with kidney failure?","volume":"104","author":"Dr\u00fceke","year":"2023","journal-title":"Kidney Int"},{"key":"2026082009363719100_aajag032-B28","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1093\/ckj\/sfad258","article-title":"Will another trial CONVINCE nephrologists to adopt high-dose haemodiafiltration over conventional haemodialysis?","volume":"16","author":"Mayne","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026082009363719100_aajag032-B29","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/ndt\/gfad136","article-title":"Haemodiafiltration for all: are we CONVINCEd?","volume":"38","author":"Shroff","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026082009363719100_aajag032-B30","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1093\/ckj\/sfad088","article-title":"Unmasking the CONVINCE trial: is hemodiafiltration ready to steal the spotlight in real-world practice?","volume":"16","author":"Meena","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026082009363719100_aajag032-B31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1056\/NEJMe2307709","article-title":"Improving dialysis techniques for patients?","volume":"389","author":"Golper","year":"2023","journal-title":"N Engl J Med"},{"key":"2026082009363719100_aajag032-B32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2026082009363719100_aajag032-B33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jclinepi.2017.12.020","article-title":"Electronic medical records can be used to emulate target trials of sustained treatment strategies","volume":"96","author":"Danaei","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"2026082009363719100_aajag032-B34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10654-017-0269-z","article-title":"Target trial emulation: teaching epidemiology and beyond","volume":"32","author":"Labrecque","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2026082009363719100_aajag032-B35","doi-asserted-by":"publisher","first-page":"k182","DOI":"10.1136\/bmj.k182","article-title":"How to estimate the effect of treatment duration on survival outcomes using observational data","volume":"360","author":"Hern\u00e1n","year":"2018","journal-title":"BMJ"},{"key":"2026082009363719100_aajag032-B36","doi-asserted-by":"publisher","first-page":"e210015","DOI":"10.1001\/jamanetworkopen.2021.0015","article-title":"Emulation of a target trial to assess the effect of statins on cardiovascular disease in people living with HIV","volume":"4","author":"Caniglia","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026082009363719100_aajag032-B37","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2215\/CJN.15081021","article-title":"Target trial emulation of renin\u2013angiotensin system inhibition in advanced chronic kidney disease","volume":"17","author":"Carrero","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026082009363719100_aajag032-B38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1182\/bloodadvances.2020003636","article-title":"Comparative effectiveness of oral anticoagulants in cancer-associated venous thromboembolism: a target trial emulation","volume":"5","author":"Fralick","year":"2021","journal-title":"Blood Adv"},{"key":"2026082009363719100_aajag032-B39","doi-asserted-by":"publisher","first-page":"e55015","DOI":"10.2196\/55015","article-title":"Digital twins for clinical and operational decision making: scoping review","volume":"27","author":"Riahi","year":"2025","journal-title":"J Med Internet Res"},{"key":"2026082009363719100_aajag032-B40","first-page":"1252","article-title":"Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines in U.S. veterans","volume":"385","author":"Dickerman","year":"2021","journal-title":"N Engl J Med"},{"key":"2026082009363719100_aajag032-B41","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"2026082009363719100_aajag032-B42","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes","volume":"362","author":"ACCORD Study Group","year":"2010","journal-title":"N Engl J Med"},{"key":"2026082009363719100_aajag032-B43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/ckj\/sfad190","article-title":"Trial design of the MOTheR HDx study: a multicentre, open-label, prospective, randomized study","volume":"17","author":"de Sequera","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026082009363719100_aajag032-B44","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/ndt\/gfv302","article-title":"Randomized placebo-controlled dose-ranging and pharmacodynamic study of oral roxadustat (FG 4592) in ESRD","volume":"30","author":"Provenzano","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026082009363719100_aajag032-B45","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1056\/NEJMoa1901713","article-title":"Roxadustat for anemia in patients with kidney disease not receiving dialysis: phase II study","volume":"381","author":"Chen","year":"2019","journal-title":"N Engl J Med"},{"key":"2026082009363719100_aajag032-B46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41746-020-0254-1","article-title":"Ethical framework for AI-based clinical decision support tools: the importance of explicability, transparency, and accountability","volume":"3","author":"Lindvall","year":"2020","journal-title":"NPJ Digit Med"},{"key":"2026082009363719100_aajag032-B47","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel-group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"2026082009363719100_aajag032-B48","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1016\/S2589-7500(21)00089-4","article-title":"The need for open data standards and model reproducibility for artificial intelligence in cardiology and critical care","volume":"3","author":"Iqbal","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026082009363719100_aajag032-B49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41591-019-0540-0","article-title":"Ethical and legal challenges of artificial intelligence-driven healthcare","volume":"26","author":"Gerke","year":"2020","journal-title":"Nat Med"},{"key":"2026082009363719100_aajag032-B50","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/jmedethics-2021-107920","article-title":"Artificial intelligence in medicine: regulatory and ethical challenges","volume":"48","author":"Kluge","year":"2022","journal-title":"J Med Ethics"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/4\/663\/68611635\/aajag032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/4\/663\/68611635\/aajag032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:36:53Z","timestamp":1787233013000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/4\/663\/8716099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6,25]]},"published-print":{"date-parts":[[2026,8,20]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajag032","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,5]]}}}